More than £350,000 has been raised in honour of a gifted young equestrian who died from a rare form of cancer aged just 30.

Miranda Filmer died on 10 June 2022 having been diagnosed with neuroendocrine cancer in 2017.

Following her death, Miranda’s family launched a fundraising appeal to support a research project of global significance that could improve outcomes for patients with neuroendocrine cancer.

The project, led by leading neuroendocrine specialist Professor Martyn Caplin, could help clinicians to detect cancer-related genetic alterations in patients and better understand their cancer journey. This could increase our understanding of which treatments work better on which patients, avoiding the need for trial and error.

Using genomic profiling, researchers will explore in detail the differences in the NET cancer cells within a patient, why some of the cells are more aggressive than others, and why the cancer cells show a tendency to change their structure, and therefore their response to the available treatment.



Each year in the UK, around 6,000 people are diagnosed with a neuroendocrine cancer. The neuroendocrine tumour (NET) unit at the Royal Free Hospital has an international reputation for the care and treatment of patients with NETs.


We are so proud to be facilitating the Miranda Filmer Fund on behalf of Antonia and Charles Filmer following the loss of their daughter, Miranda. The exceptional fundraising they are doing could be genuinely transformational for the world-renowned work of the Royal Free London in the field of neuroendocrine cancer research. We are immensely grateful for their support, and for that of their wider network of donors.

Jon Spiers, Chief Executive